To what extent are topical tacrolimus or pimecrolimus associated with increased risk of skin cancer and lymphoma? Longterm results from Joelle study

Alejandro Arana, Anton Pottegard, Josephina G. Kuiper, Elizabeth Crellin, Johan Reutfors, Marcus Schmitt-Egenolf, Lars Christian Lund, Eline Houben, Helen Booth, Brian Calingaert, James A. Kaye, Karin Gembert, Kenneth J. Rothman, Daniel Dedman, Helle Kieler, Lia Gutierrez, Jesper Hallas, Susana Perez-Gutthann

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number3702
JournalPharmacoepidemiology and Drug Safety
Volume29
Issue numberSuppl. 3
Pages (from-to)568-569
Number of pages2
ISSN1053-8569
Publication statusPublished - Oct 2020
Event36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management -
Duration: 16. Sep 202017. Sep 2020

Conference

Conference36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Period16/09/202017/09/2020

Cite this